Biotech Business
Dr. Laurence Lasky, Ph.D. Joins U.S. Venture Partners
Published in Vaccine Weekly, January 16th, 2008
U.S. Venture Partners (USVP) is pleased to announce that Laurence Lasky, Ph.D., has joined the firm as a Venture Partner. Dr. Lasky will be responsible for investing in healthcare technologies specifically focusing on financing and creating world class biopharmaceutical companies pursuing the discovery, development and commercialization of new therapies to treat major unmet medical needs and biotechnology companies providing goods and services to this industry.
Dr. Lasky is a distinguished molecular biologist who is recognized internationally for his pioneering scientific work since the 1970s that helped to establish the biotechnology industry. Dr. Lasky was a founding...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2008-01-16)
More Articles from Vaccine Weekly
- Tuberculosis
Cornell researcher seeks clues to how tuberculosis infects cells - Vivax Malaria
CWRU School of Medicine has evidence vaccine against malaria will reduce disease - Immunization
Hawaii Biotech Receives Allowance to Perform West Nile Vaccine Clinical Trials - Immunization
Study data from University of Queensland provide new insights into immunization - Malaria
Report summarizes malaria study findings from Case Western Reserve University - Anthrax Vaccines
Investigators at Children's Hospital publish new data on anthrax vaccines - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
